Approximately over 3000 pharmaceuticals are prescribed in Europe. After use they are excreted by the body, and here we approach the pharmacology for humans!
January 2012 the new draft annex to the Water Framework Directive (WFD) is published by the EU. After July 2, 2013, three drugs were on "standby alert list" and are added to the priority list of suspect products.
The new system recognizes the risks arising from three drugs, hormone (mainly 17-alpha-ethinyl estradiol), estrogen (beta-estradiol) and the anti-pain (diclofenac among others). The European Commission is developing a strategy to deal with the impact of these drugs in the water for human consumption and in the aquatic environment.
Technical framed by methodologies are needed to neutralize, reduce or eliminate micropollutants in the cycle of the water. However, advanced sewage-treatment techniques have too high a cost for communities.
NO PILLS-program seeks alternative strategies via inputs rather than treatment "end of the tunnel" by covering all of all pharmacological micropollutants. In the previous NOPILLS program, studies have confirmed that 70% of residual waste consumed drug is excreted by the human body.
NO PILLS program of drug residual waste is funded by the European Union through the structural development funds Interreg IV B Northwesteurope.
5 countries are involved in the process of study and research on drug release and their consequences: Germany, Netherlands, Scotland, the Grand Duchy of Luxembourg and France through some of their institutions.
Against these disturbing reports on drug residual releases, Aguagreen can only advise you to filter your water by reverse osmosis or ultrafilter
The treatment of water to remove the residual drug release begins by ultrafiltration to a minimum. It is also the cheapest system to use and water consumption compared to reverse osmosis has the disadvantage that it to use 3 to 4 liters of water for 1 liter of pure water, but in some cases the choice is a no-brainer.
These devices ultrafilter or osmosis against drug residual releases have become essential to protect the long-term health